VEGFA and rectal cancer: An ongoing clinical trial investigates the use of vascular endothelial growth factor (VEGF)-targeted fluorescence endoscopy for response evaluation in rectal cancer patients following neoadjuvant therapy (ClinicalTrials.gov Identifier: NCT01972373).